Related Experiment Videos
Functional characterization of hepatoma-specific stem cell antigen-2
1Department of Molecular and Microbiology, Powell Gene Therapy Center and McKnight Brain Institute, University of Florida, Gainesville, Florida, USA.
Molecular Carcinogenesis
|June 2, 2004
Summary
Researchers identified stem cell antigen-2 (Sca-2) as a key tumor antigen. Inhibiting Sca-2 triggers hepatoma cell apoptosis and alters sensitivity to death signals, revealing its role in cancer progression.
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- Cancer gene profiling is crucial for diagnostics and therapeutics.
- Current technologies like cDNA microarray have limitations in identifying highly differentially expressed genes.
- Novel methods are needed for rapid and accurate identification of tumor-specific genes.
Purpose of the Study:
- To identify highly differentially expressed tumor genes in murine hepatoma cells.
- To investigate the functional role of identified genes in hepatoma cell apoptosis and signaling.
- To explore the potential of these genes as diagnostic and therapeutic targets.
Main Methods:
- Modified suppression subtractive hybridization (SSH) for gene isolation.
- Lentiviral vector-mediated small interference RNA (siRNA) for gene silencing.
- Flow cytometry and Western blotting for protein analysis.
Main Results:
- Stem cell antigen-2 (Sca-2) was identified as a highly differentially expressed tumor antigen.
- Lentiviral siRNA effectively suppressed Sca-2 expression (>90%) for over 3 months.
- Sca-2 inhibition induced rapid hepatoma cell apoptosis and altered sensitivity to TNF-alpha signaling via TNFR1.
Conclusions:
- Sca-2 is a critical signal transducer regulating death receptor-mediated apoptosis in hepatoma cells.
- Targeting Sca-2 presents a potential therapeutic strategy for cancer treatment.
- The employed SSH and siRNA method is effective for identifying and validating tumor-specific genes.